Terbium-161 DOTATATE
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Terbium-161 DOTATATE, covering 2026-02-11 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors [Phase 2]